Literature DB >> 30237809

STATINS AND BONE HEALTH: A MINI REVIEW.

Leslie R Morse1,2, Jennifer Coker1, Ricardo A Battaglino2.   

Abstract

Statins are a widely prescribed class of medications that inhibit similar pathways as the anti-resorptive bisphosphonate drugs. Statins target the mevalonate pathway by blocking HMG-CoA reductase. Several recent meta-analyses concluded statins are osteoprotective in the general population. Here we present current literature exploring the mechanisms underlying the putative osteoprotective effects of statins. We also review recent clinical studies, ranging from observational cohort studies to randomized clinical trials, testing the effect of statins on bone health in various populations.

Entities:  

Keywords:  bone loss; fracture healing; statins

Year:  2018        PMID: 30237809      PMCID: PMC6143288     

Source DB:  PubMed          Journal:  Actual osteol        ISSN: 1669-8975


  26 in total

1.  HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.

Authors:  Jie Liu; Li-Ping Zhu; Xu-Li Yang; He-Lang Huang; Dong-Qing Ye
Journal:  Bone       Date:  2013-02-04       Impact factor: 4.398

2.  Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study.

Authors:  A Montagnani; S Gonnelli; C Cepollaro; S Pacini; M S Campagna; M B Franci; B Lucani; C Gennari
Journal:  Bone       Date:  2003-04       Impact factor: 4.398

3.  Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.

Authors:  K Ohnaka; S Shimoda; H Nawata; H Shimokawa; K Kaibuchi; Y Iwamoto; R Takayanagi
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

4.  Effects of statins on bone mineral density: a meta-analysis of clinical studies.

Authors:  Bernard Uzzan; Régis Cohen; Patrick Nicolas; Michel Cucherat; Gérard-Yves Perret
Journal:  Bone       Date:  2007-03-01       Impact factor: 4.398

5.  HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.

Authors:  Y S Chung; M D Lee; S K Lee; H M Kim; L A Fitzpatrick
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  The cornucopia of "pleiotropic" actions of statins: myogenesis as a new mechanism for statin-induced benefits?

Authors:  Roberto Bolli; Buddhadeb Dawn
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

7.  Transdermal lovastatin enhances fracture repair in rats.

Authors:  Gloria E Gutierrez; James R Edwards; Ian R Garrett; Jeffry S Nyman; Brandon McCluskey; Gianni Rossini; Alda Flores; Daria B Neidre; Gregory R Mundy
Journal:  J Bone Miner Res       Date:  2008-11       Impact factor: 6.741

8.  Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.

Authors:  Lars Rejnmark; Niels Henrik Buus; Peter Vestergaard; Lene Heickendorff; Frederik Andreasen; Mogens Lytken Larsen; Leif Mosekilde
Journal:  J Bone Miner Res       Date:  2004-02-16       Impact factor: 6.741

9.  Locally delivered lovastatin nanoparticles enhance fracture healing in rats.

Authors:  I R Garrett; G E Gutierrez; G Rossini; J Nyman; B McCluskey; A Flores; G R Mundy
Journal:  J Orthop Res       Date:  2007-10       Impact factor: 3.494

10.  Locally applied Simvastatin improves fracture healing in mice.

Authors:  Björn Skoglund; Per Aspenberg
Journal:  BMC Musculoskelet Disord       Date:  2007-09-27       Impact factor: 2.362

View more
  2 in total

Review 1.  Crosstalk of Brain and Bone-Clinical Observations and Their Molecular Bases.

Authors:  Ellen Otto; Paul-Richard Knapstein; Denise Jahn; Jessika Appelt; Karl-Heinz Frosch; Serafeim Tsitsilonis; Johannes Keller
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

Review 2.  Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism.

Authors:  Haemin Kim; Brian Oh; Kyung-Hyun Park-Min
Journal:  Cells       Date:  2021-01-07       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.